Study RIN-PF-302 is designed to evaluate the long-term safety and tolerability of inhaled treprostinil in subjects with idiopathic pulmonary fibrosis.
- Investigator
- Ibrahim Faruqi
- Status
- Accepting Candidates
- Ages
- 40 Years - N/A
- Sexes
- All
Research at a glance
Focus
Biomarkers in Interstitial Lung Disease, Clinical Trials in Interstitial Lung Disease, Role of Th1 & Th2 pathways and biomarkers in Sarcoidosis
Active clinical trials
Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from baseline to Week 52.
- Investigator
- Ibrahim Faruqi
- Status
- Accepting Candidates
- Ages
- 40 Years - N/A
- Sexes
- All
My publications
Filter publications
10 publications
2024
Secondary Spontaneous Pneumothorax in a Patient With Interstitial Lung Disease Undergoing Routine Outpatient Pulmonary Function Tests.
Cureus
PubMed • Publisher's site2020
A 36-Year-Old Woman Presenting With Left Upper Quadrant Discomfort, Encephalopathy, and Respiratory Failure.
Chest
PubMed • Publisher's site2020
Pulmonary Embolism in Acute Asthma Exacerbation: Clinical Characteristics, Prediction Model and Hospital Outcomes.
Lung
PubMed • Publisher's site2018
Short-term outcomes of pulmonary embolism: A National Perspective.
Clinical cardiology
PubMed • Publisher's site2017
The Utility of the "Shred Sign" in the Diagnosis of Acute Respiratory Distress Syndrome Resulting from Multifocal Pneumonia.
American journal of respiratory and critical care medicine
PubMed • Publisher's site